152 related articles for article (PubMed ID: 9290697)
1. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation.
Woloschak M; Yu A; Post KD
Mol Carcinog; 1997 Aug; 19(4):221-4. PubMed ID: 9290697
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
[TBL] [Abstract][Full Text] [Related]
3. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of the P16INK4a gene product in human pituitary tumors.
Woloschak M; Yu A; Xiao J; Post KD
Cancer Res; 1996 Jun; 56(11):2493-6. PubMed ID: 8653683
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
7. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
Simpson DJ; McNicol AM; Murray DC; Bahar A; Turner HE; Wass JA; Esiri MM; Clayton RN; Farrell WE
Clin Cancer Res; 2004 Mar; 10(5):1780-8. PubMed ID: 15014032
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
12. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.
Martinez-Delgado B; Fernandez-Piqueras J; Garcia MJ; Arranz E; Gallego J; Rivas C; Robledo M; Benitez J
Leukemia; 1997 Mar; 11(3):425-8. PubMed ID: 9067584
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
16. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
17. P16 overexpression in pituitary adenomas studied by immunohistochemistry and in situ hybridization.
Yi J; Yu D; Chen Y; Xiong W; Li X; Shen J; Tang X
Chin Med J (Engl); 2000 Feb; 113(2):162-6. PubMed ID: 11775544
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Herman JG; Merlo A; Mao L; Lapidus RG; Issa JP; Davidson NE; Sidransky D; Baylin SB
Cancer Res; 1995 Oct; 55(20):4525-30. PubMed ID: 7553621
[TBL] [Abstract][Full Text] [Related]
20. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.
Belinsky SA
Exp Lung Res; 1998; 24(4):463-79. PubMed ID: 9659578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]